Abstract:OBJECTIVE:To investigate the feasibility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in differentiating musculoskeletal tumors with different behaviours of pathological findings before therapy. METHODS:A total of 34 subjects of musculoskeletal tumors were involved in this retrospective analysis. DCE-MRI was performed using a fat-saturated 3D VIBE (volumetric interpolated breath-hold exam) imaging sequence with following parameters: FA, 10 degree; TR/TE, 5.6/2.4 ms; slice thickness, 4.0 mm with no intersection gap; field of view, 310 mm×213 mm; matrix, 256×178; voxel size, 1.2 mm×1.2 mm×4.0 mm; parallel imaging acceleration factor. The actuation time for the DCE-MRI sequence was 255 s with a temporal resolution of 5 s and 40 image volumes. Using pathological results as a gold standard, tumors were divided into benign, borderline and malignant tumors. Toft's model was used for calculation of K(trans) (volume transfer constant), Ve (extravascular extracellular space distribute volume per unit tissue volume) and Kep (microvascular permeability reflux constant). Those parameters were compared between the lesions and the control tissues using paired t tests. The one-way analysis of variance was used to assess the difference among benign, borderline and malignant tumors. P values <0.05 difference was statistically significant. RESULTS:Based on the WHO Classification of Tumours of Soft Tissue and Bone(2012) criteria, 34 patients were divided into three groups: 11 for benign tumors, 12 for borderline tumors, and 11 for malignancies. Compared with control tissues, K(trans) and Kep showed no difference, but Ve was increased in benign tumors, Kep showed no difference, but K(trans) and Ve were increased in borderline tumors,K(trans), Kep and Ve were increased in malignant tumors. K(trans) (P<0.001) and Kep (P<0.01) were significantly higher in malignant tumors than in benign and borderline tumors, but did not show any difference between benign tumors and borderline tumors. Ve was significantly higher in malignant tumors than in benign (P<0.05), but did not show any difference between malignant and borderline tumors, benign tumors and borderline tumors (P>0.05). CONCLUSION:DCE-MRI technique is useful to evaluate the pathological behaviour of musculoskeletal tumors. The quantitative analysis of DCE parameters in conjunction with conventional MR images can improve the accuracy of musculoskeletal tumor qualitative analysis.

Comparison of lung lesion assessment using free-breathing dynamic contrast-enhanced 1.5-T MRI with a golden-angle radial stack-of-stars VIBE sequence and CT

Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI

Discrimination between benign and malignant lung lesions using volumetric quantitative dynamic contrast-enhanced MRI

Free-breathing Dynamic Contrast-Enhanced MRI for Assessment of Pulmonary Lesions Using Golden-Angle Radial Sparse Parallel Imaging.

Dynamic Contrast-Enhanced Computed Tomography Functional Imaging for the Evaluation of Tumor Angiogenesis in Patients with Lung Carcinoma

Clinical usability of 3D gradient-echo-based ultrashort echo time imaging: Is it enough to facilitate diagnostic decision in real-world practice?

Comparison of Intravoxel Incoherent Motion Diffusion-Weighted Mr Imaging with Dynamic Contrast-Enhanced Mri for Differentiating Lung Cancer from Benign Solitary Pulmonary Lesions

DCE-MRI of esophageal carcinoma using star-VIBE compared with conventional 3D-VIBE

Whole-Lesion DCE-MRI Intensity Histogram Analysis for Diagnosis in Patients with Suspected Lung Cancer

[Feasibility Study of Dynamic Contrast Enhanced Magnetic Resonance Imaging Qualitative Diagnosis of Musculoskeletal Tumors].

Dynamic Contrast-enhanced MRI in Identification and Diagnosis of Metastasis of Lung Cancer

Dynamic Contrast-Enhanced MRI Perfusion Parameters Are Imaging Biomarkers for Angiogenesis in Lung Cancer

Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of lung cancer from obstructive lung consolidation: comparison and correlation with pharmacokinetic analysis from dynamic contrast-enhanced MR imaging

Feasibility of free-breathing dynamic contrast-enhanced MRI of gastric cancer using a golden-angle radial stack-of-stars VIBE sequence: comparison with the conventional contrast-enhanced breath-hold 3D VIBE sequence

Respiratory Motion-Compensated Radial Dynamic Contrast-Enhanced (Dce)-Mri of Chest and Abdominal Lesions

Quantitative Analysis of Pharmacokinetic Parameters Using Clinical Lung Dynamic Contrast-Enhanced MR Image

Improving Dynamic Contrast-Enhanced MRI of the Lung Using Motion-Weighted Sparse Reconstruction: Initial Experiences in Patients

Characteristics of 3.0T Dynamic Contrast-enhanced Magnetic Resonance Imaging of Lung Cancer and Its Correlation with Microvessel Density

Assessing the Performance of Benign and Malignant Breast Lesion Classification with Bilateral TIC Differentiation and Other Effective Features in DCE-MRI

Diffusion-weighted MRI for differential diagnosis of pulmonary tuberculosis-like lesions:A pilot study

Discrimination Between Benign and Malignant Breast Lesions Using Volumetric Quantitative Dynamic Contrast-Enhanced MR Imaging.